Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02805504 · ClinicalTrials.gov registry record · Phase 4
Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures
A Phase 4 study, sponsored by Loma Linda University.
- Completed
- Registry status
- Phase 4
- Development phase
- 136
- Enrollment target
NCT02805504 is a Phase 4 study that has completed, run by Loma Linda University. The registered enrollment target is 136 participants.
The verdict
NCT02805504, a Phase 4 study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 136 participants
- Enrollment target
Study Summary
A prospective, randomized controlled study to determine the efficacy of liposomal bupivacaine given by local injection at all the wound sites in patients undergoing urologic surgeries.
Interventions
- DRUG Exparel
- DRUG Marcaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2016-07-11 |
| Est. Completion | 2022-05-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02805504
The ClinicalTrials.gov registry entry for NCT02805504 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exparel is the first listed.
NCT02805504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02805504 about?
NCT02805504 is a clinical study titled "Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures". A prospective, randomized controlled study to determine the efficacy of liposomal bupivacaine given by local injection at all the wound sites in patients undergoing urologic surgeries.
What is the current status of trial NCT02805504?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 136 participants. The study started on 2016-07-11. Estimated completion is 2022-05-09.
What interventions are being tested in trial NCT02805504?
The interventions under investigation include: Exparel (DRUG), Marcaine (DRUG).
Who is sponsoring clinical trial NCT02805504?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.